STOCK TITAN

Emerson Acquires Glue Inc. to Accelerate AI-Driven Test & Measurement Innovation

(Neutral)
(Very Positive)

Emerson (NYSE: EMR) announced the acquisition of Glue Inc., developer of the AI-enabled validation and test software Glue Studio, on August 6, 2026. Glue Studio offers AI-centric capabilities for test generation and planning.

According to Emerson, the deal supports its strategy to expand software-defined, data-centric solutions across the Test & Measurement business and the NI portfolio. Glue Studio technology is intended to enhance NI Nigel™ AI, described as the industry’s first AI optimized for test and measurement workflows, which is embedded in NI software and trained on test system design, methodologies and data analysis.

Emerson said Nigel provides context-aware guidance throughout product development and can support productivity improvements such as faster product releases and increased customer engagement. Integrating Glue Studio is expected to improve connected validation workflows, traceability and the path from design to verified performance. Transaction terms were not disclosed.

Loading...
Loading translation...

Positive

  • Acquisition of Glue Inc. adds AI-enabled validation and test software Glue Studio
  • Deal supports Emerson’s software-defined, data-centric Test & Measurement strategy
  • Glue Studio expected to enhance NI Nigel™ AI capabilities in test workflows
  • Emerson highlights potential productivity gains such as faster product releases

Negative

  • Acquisition terms were not disclosed, limiting insight into financial impact

Market Context

Recent AI announcements were associated with 1.68% and 0.92% 24-hour reactions, while the acquisitio...
Analysis

Recent AI announcements were associated with 1.68% and 0.92% 24-hour reactions, while the acquisition's undisclosed terms limit direct comparability; insider context also recorded net selling.

Key Figures

Announcement date: Aug. 6, 2026
1 metrics
Announcement date Aug. 6, 2026 Acquisition announcement

Historical Context

5 past events · Latest: Jul 28 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jul 28 AI portfolio expansion Positive +1.7% New NI Nigel AI enhancements reportedly reduced representative test development time by up to 50 percent.
Jul 27 AI agent launch Positive +0.9% Five Ovation AI Agents expanded Emerson's intelligent automation capabilities for power and water industries.
Jul 16 Refinery software launch Positive +2.1% New scheduling and blending software capabilities targeted refinery margins and faster responses to market changes.
Jul 14 Earnings date scheduling Neutral +0.1% Emerson scheduled its third-quarter fiscal 2026 results release and investor conference call.
May 27 Strategic partnership Positive -0.9% Emerson and Aramco agreed to co-develop next-generation corrosion management solutions.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Positive AI and software announcements had positive reactions, while a prior partnership announcement diverged negatively.

Key Terms

software-defined, traceability
2 terms
software-defined technical
"software-defined, data-centric capabilities across Test & Measurement's NI portfolio"
software-defined describes systems where functions traditionally built into physical hardware are implemented and controlled by software, letting one physical device behave like many by changing code. Think of it as a programmable appliance that can be reconfigured with updates rather than replaced. Investors care because it can cut capital costs, speed new features to market, enable subscription or service revenue, and make products more adaptable — but it also shifts value toward software skill and ongoing maintenance.
traceability technical
"connect validation workflows, enhance traceability"
Traceability is the ability to follow a product, component, or piece of data backward and forward through every step of its lifecycle, like reading a parcel’s tracking history to see where it came from and where it went. For investors, strong traceability lowers risk by making recalls, quality problems, and regulatory breaches easier and cheaper to manage, while boosting consumer trust, supply-chain efficiency, and the reliability of reported information.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

ST. LOUIS, Aug. 6, 2026 /PRNewswire/ -- Global automation leader Emerson (NYSE: EMR) today announced it has acquired Glue Inc., an innovator in advancing intelligent validation and test through its AI-enabled software product Glue Studio. Glue Studio features specialized AI-centric capabilities for test generation and planning. The acquisition strengthens Emerson's strategy to deliver more software-defined, data-centric capabilities across Test & Measurement's NI portfolio.

Emerson

Glue Studio's technology accelerates the continued investment in Emerson's NI Nigel™ AI, the industry's first AI specifically optimized for test and measurement workflows. Nigel reflects Emerson's vision for AI in test and measurement: domain-specific, deeply integrated, and designed to improve human decision-making. Nigel is embedded directly within NI software and trained in test system design, methodologies and data analysis, providing context-aware guidance throughout product development. As a result, Nigel delivers productivity improvements including faster product releases and increased customer engagement. Glue Studio's capabilities will strengthen Nigel's ability to connect validation workflows, enhance traceability and accelerate the path from design to verified performance.

"Glue Studio brings highly complementary capabilities that align closely with Emerson's strategy to lead in software-defined test and measurement," said Ritu Favre, Group President of Test & Measurement at Emerson. "By integrating Glue Studio's AI-enabled validation technology into Nigel, we are enhancing our ability to extend AI-assisted test planning and validation across the engineering workflow and help customers improve engineering decisions."

For more information on NI Nigel™ AI, visit: Explore NI Nigel AI.

Terms of the transaction were not disclosed.

About Emerson
Emerson (NYSE: EMR) is a global automation leader delivering solutions for the most demanding technology challenges. Headquartered in St. Louis, Missouri, Emerson is engineering the autonomous future, enabling customers to optimize operations and accelerate innovation. For more information, visit Emerson.com.

Forward-Looking and Cautionary Statements
Statements in this press release that are not strictly historical may be "forward-looking" statements, which represent management's expectations, based on currently available information. Actual results, performance or achievements could differ materially from those expressed in any forward-looking statement. Any forward-looking statements in this press release speak only as of the date of this press release. Emerson undertakes no obligation to update any such statements to reflect new information or later developments. Examples of risks and uncertainties that may cause our actual results or performance to be materially different from those expressed or implied by forward looking statements include the scope, duration and ultimate impacts of the Russia-Ukraine, Middle East and other global conflicts, as well as economic and currency conditions, market demand, pricing, protection of intellectual property, cybersecurity, tariffs, competitive and technological factors, inflation, among others, as set forth in the Company's most recent Annual Report on Form 10-K and subsequent reports filed with the SEC. The outlook contained herein represents the Company's expectation for its consolidated results, other than as noted herein.

Emerson uses our Investor Relations website, https://ir.emerson.com/, as a means of disclosing information which may be of interest or material to our investors and for complying with disclosure obligations under Regulation FD. Accordingly, investors should monitor our Investor Relations website, in addition to following our press releases, SEC filings, public conference calls, webcasts, and social media. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.

Contacts
Investors
Doug Ashby
(314) 553-2197

Media
Joseph Sala / Greg Klassen / Connor Murphy
Joele Frank, Wilkinson Brimmer Katcher
(212) 355-4449

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/emerson-acquires-glue-inc-to-accelerate-ai-driven-test--measurement-innovation-302844219.html

SOURCE Emerson

FAQ

What did Emerson (EMR) announce about Glue Inc. on August 6, 2026?

Emerson announced it acquired Glue Inc., the company behind AI-enabled validation software Glue Studio. According to Emerson, the acquisition supports its software-defined, data-centric Test & Measurement strategy and is intended to enhance NI Nigel AI for test and measurement workflows.

How does Glue Studio support Emerson’s NI Nigel AI for test and measurement?

Glue Studio provides AI-centric capabilities for test generation and planning that will be integrated into NI Nigel AI. According to Emerson, this is expected to strengthen connected validation workflows, improve traceability, and help accelerate the path from design to verified performance in test environments.

What is NI Nigel AI and how is Emerson using it in test and measurement?

NI Nigel AI is described as an AI optimized for test and measurement workflows and embedded in NI software. According to Emerson, Nigel is trained in test system design, methodologies and data analysis, providing context-aware guidance to support faster product releases and higher customer engagement.

Did Emerson (EMR) disclose the financial terms of the Glue Inc. acquisition?

Emerson did not disclose the financial terms of the Glue Inc. acquisition. According to Emerson, the announcement focuses on strategic and technology benefits, including enhancing NI Nigel AI and expanding software-defined, data-centric capabilities in its Test & Measurement portfolio.

How could Emerson’s acquisition of Glue Inc. impact EMR’s Test & Measurement portfolio?

The acquisition is intended to strengthen Emerson’s Test & Measurement portfolio by integrating Glue Studio into NI Nigel AI. According to Emerson, this should expand AI-assisted test planning and validation capabilities and better connect engineering workflows across design, validation, and product development.